Most readers would already be aware that Masterflex's (ETR:MZX) stock increased significantly by 15% over the past three months. Given the company's impressive performance, we decided to study its ...

(Reuters) - U.S. lab products provider Avantor Inc will buy Masterflex from privately held Antylia Scientific in a $2.9 billion all-cash deal to beef up its COVID-19 therapy and vaccine manufacturing ...

For those who don't know, ROCE is a measure of a company's yearly pre-tax profit (its return), relative to the capital employed in the business. To calculate this metric for Masterflex, this is the ...

RADNOR, Pa., Nov. 1, 2021 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies & ...

Visit a quote page and your recently viewed tickers will be displayed here.

U.S. lab products provider Avantor Inc will buy Masterflex from privately held Antylia Scientific in a $2.9 billion all-cash deal to beef up its COVID-19 therapy and vaccine manufacturing operations.

Masterflex SE (ETR:MZX) last week reported its latest half-yearly results, which makes it a good time for investors to dive in and see if the business is performing in line with expectations. It was a ...

U.S. lab products provider Avantor Inc said on Tuesday it would buy Masterflex from privately held Antylia Scientific in a $2.9 billion all-cash deal that would strengthen its COVID-19 therapy and ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

Following the acquisition, Avantor will have access to Masterflex’s various bioproduction operations. Avantor announced on Nov. 1, 2021, that it had completed a previously announced acquisition of the ...

Consolidated revenue increased by 3.4% to EUR 53.4 million (previous year: EUR 51.6 million) Another record result with a slightly improved operating EBIT margin of 14.7% (previous year: 14.6%) ...

Expansion of production capacities to meet dynamic demand Availability of skilled workers, high-quality standards and favourable locations Target of doubling sales in ...